Search…

East Asia Pharmaceuticals: Net loss of 30.2283 million yuan in the first half of 2025.

28/08/2025

East Asia Pharmaceuticals announced that its operating income in the first half of 2025 was 416 million yuan, a year-on-year decrease of 35.85%. The net profit attributable to shareholders of the listed company was -30.2283 million yuan, a year-on-year decrease of 193.09%. The company will not distribute profits or increase share capital from reserves in the first half of 2025.

Latest

1 m ago

Anhui Wan Tong Expressway (00995.HK) released its interim performance results, with a net profit attributable to shareholders of 961 million yuan, an increase of 4.14% year-on-year.

2 m ago

Guotai SeaTrend Securities: Enterprises that are strategically positioning themselves in the lithium sulfide market are expected to benefit as demand for solid-state batteries gradually increases.

2 m ago

Zhejiang Commercial Bank (02016.HK) announced its interim results, with a net profit attributable to shareholders of 7.667 billion yuan, a year-on-year decrease of 4.15%.

2 m ago

Vertex Technology Holdings (02458.HK) released its interim results, with a net profit attributable to shareholders of 53.712 million yuan, a year-on-year increase of 110.3%.

3 m ago

Runhua Service (02455.HK) released its interim results with a net profit attributable to shareholders of 21.723 million yuan, an increase of 23.72% year-on-year.

See all latest